Halozyme Therapeutics
HALO
#2447
Rank
$5.78 B
Marketcap
$45.48
Share price
-0.13%
Change (1 day)
29.94%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2023 (TTM): $0.34 B

According to Halozyme Therapeutics's latest financial reports the company's current earnings (TTM) are $0.34 B. In 2022 the company made an earning of $0.24 B an increase over its 2021 earnings that were of $0.24 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) $0.34 B39.94%
2022 $0.24 B0.16%
2021 $0.24 B92.2%
2020 $0.12 B-278.96%
2019 -$72.26 M-9.45%
2018 -$79.8 M-229.51%
2017 $61.61 M-160.48%
2016 -$0.11 B216.03%
2015 -$32.24 M-52.86%
2014 -$68.38 M-18.09%
2013 -$83.48 M55.88%
2012 -$53.56 M169.94%
2011 -$19.84 M-63.44%
2010 -$54.26 M-7.19%
2009 -$58.46 M15.91%
2008 -$50.44 M83.89%
2007 -$27.43 M78.1%
2006 -$15.41 M16%
2005 -$13.28 M45.24%
2004 -$9.15 M682.42%
2003 -$1.17 M1659.12%
2002 -$0.07 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$21.36 B 6,032.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.26 B 837.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.56 B 2,070.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.26 B 1,984.47%๐Ÿ‡ซ๐Ÿ‡ท France
-$1 M-100.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.38 M-102.98%๐Ÿ‡บ๐Ÿ‡ธ USA